Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.39 |
| ▸ | MAOB | P27338 | 6/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL779443 | 0.87 | NPC1 (0.58) | NPC1RAB9AMAPTMAPK1SMN1; SMN2 | |
| SCHEMBL15266266 | 0.82 | SHBG (0.41) | NPC1RAB9AMAPTMAPK1SMN1; SMN2 | |
| SCHEMBL199691 | 0.81 | CNR2 (0.46) | CNR2 | |
| SCHEMBL3292125 | 0.79 | NPC1 (0.52) | NPC1RAB9AMAPTMAPK1SMN1; SMN2 | |
| SCHEMBL3625528 | 0.79 | NPC1 (0.52) | NPC1RAB9AMAPTMAPK1SMN1; SMN2 | |
| SCHEMBL5552840 | 0.79 | NPC1 (0.52) | NPC1RAB9AMAPTMAPK1SMN1; SMN2 | |
| SCHEMBL200171 | 0.78 | SHBG (0.61) | MAPTMAPK1SMN1; SMN2LMNAPOLB | |
| SCHEMBL12465285 | 0.78 | NPC1 (0.47) | NPC1RAB9AMAPTMAPK1SMN1; SMN2 | |
| SCHEMBL199438 | 0.78 | CNR2 (0.49) | CNR2 | |
| SCHEMBL13016 | 0.77 | NPC1 (0.50) | NPC1RAB9AMAPTMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111433962-B | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2023-07-14 | — | — | CN | claimed |
| US-20220231337-A1 | Nonaqueous Electrolytic Solution | CENTRAL GLASS CO., LTD. (JP) | 2022-07-21 | — | — | US | claimed |
| US-20220231338-A1 | Nonaqueous Electrolytic Solution | CENTRAL GLASS CO., LTD. (JP) | 2022-07-21 | — | — | US | claimed |
| EP-3965204-A1 | NONAQUEOUS ELECTROLYTE SOLUTION | Central Glass Co., Ltd. (JP) | 2022-03-09 | — | — | EP | claimed |
| CN-113939938-A | Non-aqueous electrolyte | 中央硝子株式会社 | 2022-01-14 | — | — | CN | claimed |
| CN-113924677-A | Non-aqueous electrolyte | 中央硝子株式会社 | 2022-01-11 | — | — | CN | claimed |
| US-20210184260-A1 | Electrolyte Solution for Nonaqueous Electrolyte Batteries, and Nonaqueous Electrolyte Battery Using Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2021-06-17 | — | — | US | claimed |
| EP-3723181-A1 | ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE BATTERIES, AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | Central Glass Company, Limited (JP) | 2020-10-14 | — | — | EP | claimed |
| CN-111433962-A | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2020-07-17 | — | — | CN | claimed |
| US-7547749-B2 | Triazine compounds, polymers comprising triazine structural units, and method | SABIC INNOVATIVE PLATICS IP B.V. (NL) | 2009-06-16 | — | — | US | claimed |
| US-6613943-B2 | Intermediates for 4-substituted-2,5-diaminophenol derivatives as phenolic cyan couplers for color photography; deblocking the 2-acyl group by hydrolysis | EASTMAN KODAK COMPANY | 2003-09-02 | — | — | US | claimed |
| US-20030109716-A1 | 5-ACYLAMINO-2-AMINO-4-SUBSTITUTED-PHENOL COMPOUNDS AND METHOD OF USING THEM | EASTMAN KODAK COMPANY | 2003-06-12 | — | — | US | claimed |
| US-20030109753-A1 | 4-acylamino-2-hydroxy-5-substituted-acylanilide compounds and method of using them | EASTMAN KODAK COMPANY | 2003-06-12 | — | — | US | claimed |
| EP-1316550-A1 | 6-Acylamino-5-substituted-benzoxazol-2-one compounds and method for using them | EASTMAN KODAK COMPANY (US) | 2003-06-04 | — | — | EP | claimed |
| EP-1316544-A1 | 5-acylamino-2-amino-4-substituted-phenol compounds and method of using them | EASTMAN KODAK COMPANY (US) | 2003-06-04 | — | — | EP | claimed |
| US-20030078347-A1 | Triazine compounds, polymers comprising triazine structural units, and method | GENERAL ELECTRIC COMPANY | 2003-04-24 | — | — | US | claimed |
| WO-2003024939-A2 | TRIAZINE COMPOUNDS POLYMERS COMPRISING TRIAZINE STRUCTURAL UNITS, AND PROCESSES FOR THE PREPARATION OF THESE POLYMERS | GENERAL ELECTRIC COMPANY (US) | 2003-03-27 | — | — | WO | claimed |
| US-6525219-B1 | Chemical intermediates for cyan dye forming couplers; deblocking, hydrolysis, acylation | EASTMAN KODAK COMPANY | 2003-02-25 | — | — | US | claimed |
| US-6482953-B1 | 2-benzyloxy-4-nitro-5-substituted-acylanilide compounds and method of using them | EASTMAN KODAK COMPANY | 2002-11-19 | — | — | US | claimed |
| US-6476202-B1 | 5-acylamino-2-arylazo, nitro, or nitroso-4-substituted-phenol compounds and method of using them | EASTMAN KODAK COMPANY | 2002-11-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109753-A1 | 4-acylamino-2-hydroxy-5-substituted-acylanilide compounds and method of using them | CBR3, AADAC, HAAO | NPC1 2847/4885RAB9A 1906/4885MAPT 4684/4885 |
| US-20030109716-A1 | 5-ACYLAMINO-2-AMINO-4-SUBSTITUTED-PHENOL COMPOUNDS AND METHOD OF USING THEM | AADAT, AAAS, ANXA7 | NPC1 4256/4885RAB9A 1371/4885MAPT 2670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.